- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Actelion offered frozen yoghurt from its ERS Congress exhibition stand. The Panel ruled this went beyond subsistence, breached Clause 22.1, and failed…
CSL Behring challenged Sobi’s public charity ball invitation as excessive hospitality/disguised promotion. PMCPA found the event was open ticket purchase, not aimed…
Anonymous CCG-linked complaint alleged Galen’s Trustsaver website misled on NHS savings for Laxido. Panel found the basis of comparisons and savings methodology…
Anonymous complaint alleged coercive funding and audit/workshop activity linked to prescribing influence. Panel found no evidence to support inducement allegations and ruled…
At an international congress, UK prescribing info and UK pricing on Vizamyl materials implied UK availability when the product was not commercially…
A Pulse online rolling banner ad for Nicorette used the unqualified tagline “Do something incredible”. The Panel found it implied “incredible” product…
Alliance reps distributed a “Dear UK Healthcare Professional” letter highlighting EMPA‑REG CV outcomes for Jardiance. PMCPA ruled it promoted an unlicensed CV…
Anonymous complainant alleged Kyntheum was promoted to the public and ‘well tolerated’ was misleading. Panel found materials were internal, access controlled and…
GSK challenged a Takeda Actos mailer that mentioned Competact without stating its insulin contraindication. Panel found breaches, but the Appeal Board ruled…
A GP complained Arcoxia USB packaging lacked the approved name (etoricoxib). PMCPA held the box+USB was a promotional aid and brand name…
Takeda challenged a GSK Avandia FDA-related press release on gsk.com as UK-directed and misleading. The Panel found it did not specifically refer…
Anonymous alleged pharma-funded conference hospitality (hotel/food/cultural programme). Panel found Janssen-Cilag’s £2,000 educational grant and speaker support was acceptable; no evidence it funded…
Anonymous complaint said a Qvar ad in Pulse used partially clothed people and undermined the serious nature of medicines. Panel found the…
DTB criticism triggered a PMCPA case on Pfizer’s Exubera materials claiming “maintains long-term glycaemic control”. Panel found the unqualified long-term claim misleading…
Novartis’ Femara leavepiece implied extra benefit in node-positive/chemo subgroups vs overall trial effect, and a press release claimed licensing across the “entire”…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.